DOI: 10.1055/s-00000133

Gastroenterologie up2date

LinksSchließen

Referenz

Tabernero JM, van Cutsem E, Sastre J. et al.
An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results. 
JCO 2004; 22: 3512-  

Bibliographische Angaben herunterladen

Suchen in: